Company intelligence / Profile preview

Intelligencia AI

New York, New York, United Statesintelligencia.ai ↗

Ownership: Private
Employees: ~110
Development stage: Other

Overview

Intelligencia AI has developed and prospectively validated an AI-driven platform that predicts the probability of success for clinical-stage assets and portfolios. Their technology has demonstrated strong performance in identifying high-potential biotech companies and optimizing portfolio returns in back-testing and real-world validation scenarios.[6] The company’s solutions are used by large pharmaceutical companies as well as mid-size to smaller biotechs to de-risk clinical development decisions.[1][2]

Industry: Drug Discovery Services

Partnerships

Collaborates with global pharmaceutical companies and mid-size/small biotech firms on risk assessment and portfolio optimization projects. Specific partners are not publicly listed.

Beyond the preview

Go deeper on Intelligencia AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intelligencia AI.

Explore the full profile